Primary cutaneous CD30+ large cell B-cell lymphoma: A series of 10 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 1, 2006, Pages 7-11

  Magro, Cynthia M ^a   Nash, Jason W ^a   Werling, Robert W ^a   Porcu, Pierluigi ^b   Crowson, Neil ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

B cell lymphoma; CD30; Skin

Indexed keywords

CD20 ANTIBODY; CD30 ANTIGEN; LEUKOSIALIN; METHOTREXATE; PROTEIN BCL 2;

AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CAUSE OF DEATH; CELL INFILTRATION; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMMUNOBLASTIC LYMPHOMA; LARGE CELL LYMPHOMA; LYMPHOID HYPERPLASIA; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD30; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 33645137392     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000143347.58174.91     Document Type: Article

References (31)

1. Kazakov DV, Burg G, Kempf W. Primary cutaneous B-cell lymphomas and pseudolymphamas: a review of histopathological features. Cesk Patol. 2002;38:147-154.
2. Servitje O, Gallardo F, Estrach T, et al. Primary cutaneous marginal zone B-cell lymphoma; a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol. 2002;147:1147-1158.
3. Prince HM, Yap LM, Blum R, et al. Primary cutaneous B-cell lymphomas. Clin Exp Dermatol. 2003;28:8-12.
4. Paulli M, Viglio A, Vivenza D, et al. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controersial clinicopathologic entity. Hum Pathol. 2002;33:937-943.
5. Kerl H, Fink-Puches R, Cerroni L. Clinical aspects and pathology of primary cutaneous B-cell lymphomas. Recent Results Cancer Res. 2002;160:294-300.
6. Krishnan J, Tomaszewaki MM, Kao GF. Primary cutaneous CD30-positive anaplastic large cell lymphomas: report of 27 cases. J Cutan Pathol. 1993;20:193-202.
7. Kummer JA, Vermeer MH, Dukers D, et al. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol. 1997;109:636-640.
8. Stein H, Foss HD, Durkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681-3695.
9. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30(Ki-1) positive lymphoproliferative disorders. J Am Acad Dermatol. 1993;28:973-980.
10. Wood G. Analysis of the t(2:5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Leuk Lymphoma. 1998;29:93-101.
11. Segal GH, Shick HE, Tubbs RR, et al. In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol. 1994;3:170-177.
12. Pringle JH, Ruprai AK, Primrose L, et al. In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten-labeled oligonucleotide probes. J Pathol. 1990;162:197-207.
13. Nuovo GJ. In situ PCR: protocols and applications. PCR Methods Appl. 1995;4:S151-S167.
14. Nathan DL, Belsito DV. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol. 1998;38:806-809.
15. El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctiovitis. Br J Ophthamol. 2002;86:1175-1180.
16. Schwarting R, Gerdes J, Durkop H, et al. Ber H-2: a new anti-Kil (CD30) monoclonal antibody directed at a formalin-resistant epitope. Blood. 1989;74:1678-1689.
17. Lai R, Medeiros LJ, Dabbagh L, et al. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma. Mod Pathol. 2000;13:223-228.
18. Noorduyn LA, de Bruin PC, van Heerde P, et al. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol. 1994;47:33-37.
19. Paulli M, Berti E, Rosso R. et al. CD30/Ki-1 positive lymphoproliferative disorders of the skin - clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol. 1995;13:1343-1354.
20. Herrera E, Gallardo M, Bosch R, et al. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma. J Cutan Pathol. 2002;29:181-184.
21. Beylot-Barry M, Vergier B, Masquelier B, et al. The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol. 1999;23:1208-1216.
22. Watabe H, Kawakami T, Soma Y, et al. Primary cutaneous T-cell-rich B-cell lymphoma in a zosteriform distribution associated with Epstein-Barr virus infection. J Dermatol. 2002;29:748-753.
23. Fam AG, Perez-Ordonez B, Imrie K. Primary cutaneous B-cell lymphoma during methotrexate therapy for rheumatoid arthritis. J Rheumatol. 1999;27:1546-1549.
24. Scarabello A, Leinweber B, Ardigo M, et al. Cutaneous lymphomas with prominent granulamatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas. Am J Surg Pathol. 2002;26:1259-1268.
25. Wilder RB, Schlembach PJ, Jones D, et al. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte: very favourable and favorable, lymphocyte-predominant Hodgkin disease. Cancer. 2002;94:1731-1738.
26. Ekstrand BC, Horning SJ. Lymphocyte predominant Hodgkin's disease. Curr Oncol Rep. 2002;4:424-433.
27. Breccia M, Petti MC, D'Elia GM, et al. Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myleoid leukemia: successful treatment with a fludarabine containing regimen. Eur J Haematol. 2002;68:1-3.
28. Joly P, Vasseur E, Esteve E, et al. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas. Br J Dermatol. 1995;132:506-512.
29. Beljaards RC, Meijer CJ, Van der Putte SC, et al. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol. 1994;172:53-60.
30. Stein H. Ki-1-anaplastic large cell lymphoma: is it a discrete entity? Leuk Lymphoma. 1993;10:S81-S84.
31. Kinney MC, Kadin ME. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol. 1999;111:S56-S67.